<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rodina A</submitter><funding>NCATS NIH HHS</funding><funding>NIA NIH HHS</funding><funding>NCRR NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIH HHS</funding><pagination>397-401</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5283383</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>538(7625)</volume><pubmed_abstract>Transient, multi-protein complexes are important facilitators of cellular functions. This includes the chaperome, an abundant protein family comprising chaperones, co-chaperones, adaptors, and folding enzymes-dynamic complexes of which regulate cellular homeostasis together with the protein degradation machinery. Numerous studies have addressed the role of chaperome members in isolation, yet little is known about their relationships regarding how they interact and function together in malignancy. As function is probably highly dependent on endogenous conditions found in native tumours, chaperomes have resisted investigation, mainly due to the limitations of methods needed to disrupt or engineer the cellular environment to facilitate analysis. Such limitations have led to a bottleneck in ou</pubmed_abstract><journal>Nature</journal><pubmed_title>The epichaperome is an integrated chaperome network that facilitates tumour survival.</pubmed_title><pmcid>PMC5283383</pmcid><funding_grant_id>F32 CA192786</funding_grant_id><funding_grant_id>R03 NS050838</funding_grant_id><funding_grant_id>R21 AI090501</funding_grant_id><funding_grant_id>UL1 TR002384</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>P01 CA186866</funding_grant_id><funding_grant_id>UL1 TR000457</funding_grant_id><funding_grant_id>R21 CA158609</funding_grant_id><funding_grant_id>R01 CA103646</funding_grant_id><funding_grant_id>P50 CA192937</funding_grant_id><funding_grant_id>R21 AG028811</funding_grant_id><funding_grant_id>R01 CA119001</funding_grant_id><funding_grant_id>R01 CA172546</funding_grant_id><funding_grant_id>U01 AG032969</funding_grant_id><funding_grant_id>DP2 OD007399</funding_grant_id><funding_grant_id>UL1 RR024996</funding_grant_id><funding_grant_id>P50 CA086438</funding_grant_id><funding_grant_id>R03 MH076499</funding_grant_id><funding_grant_id>R01 CA155226</funding_grant_id><pubmed_authors>Lin O</pubmed_authors><pubmed_authors>Melnick A</pubmed_authors><pubmed_authors>Peter RI</pubmed_authors><pubmed_authors>Pressl C</pubmed_authors><pubmed_authors>Panchal P</pubmed_authors><pubmed_authors>Studer L</pubmed_authors><pubmed_authors>Gomes ED</pubmed_authors><pubmed_authors>Alpaugh M</pubmed_authors><pubmed_authors>Shimizu F</pubmed_authors><pubmed_authors>Modi S</pubmed_authors><pubmed_authors>Cesarman E</pubmed_authors><pubmed_authors>Larson SM</pubmed_authors><pubmed_authors>Pillarsetty N</pubmed_authors><pubmed_authors>Koren J</pubmed_authors><pubmed_authors>Riolo M</pubmed_authors><pubmed_authors>Zong H</pubmed_authors><pubmed_authors>Patil S</pubmed_authors><pubmed_authors>Kishinevsky S</pubmed_authors><pubmed_authors>Wang T</pubmed_authors><pubmed_authors>Chu F</pubmed_authors><pubmed_authors>Corben A</pubmed_authors><pubmed_authors>Erdjument-Bromage H</pubmed_authors><pubmed_authors>Gerecitano JF</pubmed_authors><pubmed_authors>Beattie B</pubmed_authors><pubmed_authors>Zanzonico P</pubmed_authors><pubmed_authors>Rodina A</pubmed_authors><pubmed_authors>Yan P</pubmed_authors><pubmed_authors>Caldas-Lopes E</pubmed_authors><pubmed_authors>Trondl R</pubmed_authors><pubmed_authors>Xu C</pubmed_authors><pubmed_authors>Dunphy MP</pubmed_authors><pubmed_authors>Yang C</pubmed_authors><pubmed_authors>Taldone T</pubmed_authors><pubmed_authors>Roboz GJ</pubmed_authors><pubmed_authors>Levine R</pubmed_authors><pubmed_authors>Patel HJ</pubmed_authors><pubmed_authors>Farooq MF</pubmed_authors><pubmed_authors>Guzman ML</pubmed_authors><pubmed_authors>Chiosis G</pubmed_authors><pubmed_authors>Lewis JS</pubmed_authors><pubmed_authors>Cerchietti L</pubmed_authors><pubmed_authors>Bolaender A</pubmed_authors><pubmed_authors>Hudis C</pubmed_authors></additional><is_claimable>false</is_claimable><name>The epichaperome is an integrated chaperome network that facilitates tumour survival.</name><description>Transient, multi-protein complexes are important facilitators of cellular functions. This includes the chaperome, an abundant protein family comprising chaperones, co-chaperones, adaptors, and folding enzymes-dynamic complexes of which regulate cellular homeostasis together with the protein degradation machinery. Numerous studies have addressed the role of chaperome members in isolation, yet little is known about their relationships regarding how they interact and function together in malignancy. As function is probably highly dependent on endogenous conditions found in native tumours, chaperomes have resisted investigation, mainly due to the limitations of methods needed to disrupt or engineer the cellular environment to facilitate analysis. Such limitations have led to a bottleneck in ou</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Oct</publication><modification>2025-04-18T17:46:05.872Z</modification><creation>2019-03-27T02:35:20Z</creation></dates><accession>S-EPMC5283383</accession><cross_references><pubmed>27706135</pubmed><doi>10.1038/nature19807</doi></cross_references></HashMap>